Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by MOMA Therapeutics

MOMA Therapeutics Appoints Susan Pandya, M.D., to Board of Directors and Expands Management Team
From MOMA Therapeutics
Via Business Wire
MOMA Therapeutics Provides Corporate Update and Announces Exclusive License Agreement for Selective PARP1 Inhibitor
From MOMA Therapeutics
Via Business Wire
MOMA Therapeutics Announces Initiation of Phase 1 Clinical Trial for MOMA-313, a Novel Polymerase Theta Helicase Inhibitor
From MOMA Therapeutics
Via Business Wire
MOMA Therapeutics Appoints Marc Ballas, M.D., as Head of Clinical Development, and Adam Thomas as Chief People & Experience Officer
From MOMA Therapeutics
Via Business Wire
MOMA Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer
From MOMA Therapeutics
Via Business Wire
MOMA Therapeutics Announces Five-Year Discovery Collaboration with Roche Focused on Critical Cancer Dependencies
From MOMA Therapeutics
Via Business Wire
MOMA Therapeutics Appoints Industry Leader Jeff Albers as Chair of the Board of Directors
From MOMA Therapeutics
Via Business Wire
MOMA Therapeutics Announces $150 Million Series B Financing
From MOMA Therapeutics
Via Business Wire
MOMA Therapeutics Appoints Hans Bitter, Ph.D., as Senior Vice President and Head, Data Science
From MOMA Therapeutics
Via Business Wire
MOMA Therapeutics Appoints Semi Trotto as Chief People and Experience Officer
From MOMA Therapeutics
Via Business Wire
MOMA Therapeutics Appoints Peter Hammerman, M.D., Ph.D., as Chief Scientific Officer
From MOMA Therapeutics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.